Maximal Exercise Electrocardiographic Responses and Coronary Heart Disease Mortality Among Men With Metabolic Syndrome
Autor: | Gregory A. Hand, Xuemei Sui, Carl J. Lavie, Tiimothy S. Church, Steven N. Blair, G. William Lyerly |
---|---|
Rok vydání: | 2010 |
Předmět: |
Adult
Male medicine.medical_specialty Time Factors Coronary Disease Asymptomatic Metabolic equivalent Electrocardiography Young Adult Risk Factors Internal medicine Humans Medicine cardiovascular diseases Survival rate Aged Retrospective Studies Aged 80 and over Metabolic Syndrome Exercise Tolerance Proportional hazards model business.industry Mortality rate Hazard ratio Cardiorespiratory fitness General Medicine Middle Aged Prognosis medicine.disease United States Survival Rate Exercise Test Physical therapy Cardiology Original Article medicine.symptom Metabolic syndrome business Follow-Up Studies |
Zdroj: | Mayo Clinic Proceedings. 85:239-246 |
ISSN: | 0025-6196 |
DOI: | 10.4065/mcp.2009.0509 |
Popis: | To examine the association between abnormal exercise electrocardiographic (E-ECG) test results and mortality (all-cause and that resulting from coronary heart disease [CHD] or cardiovascular disease [CVD]) in a large population of asymptomatic men with metabolic syndrome (MetS).A total of 9191 men (mean age, 46.9 years) met the criteria of having MetS. All completed a maximal E-ECG treadmill test (May 14, 1979, through April 9, 2001) and were without a previous CVD event or diabetes at baseline. Main outcomes were all-cause mortality, mortality due to CHD, and mortality due to CVD. Cox regression analysis was used to quantify the mortality risk according to E-ECG responses.During a follow-up of 14 years, 633 deaths (242 CVD and 150 CHD) were identified. Mortality rates and hazard ratios (HRs) across E-ECG responses were the following: for all-cause mortality: HR, 1.36; 95% confidence interval (CI), 1.09-1.70 for equivocal responses and HR, 1.41; 95% CI, 1.12-1.77 for abnormal responses (P(trend).001); for mortality due to CVD: HR, 1.29; 95% CI, 0.88-1.88 for equivocal responses and HR, 2.04; 95% CI, 1.46-2.84 for abnormal responses (P(trend).001); and for mortality due to CHD: HR, 1.62; 95% CI, 1.02-2.56 for equivocal responses and HR, 2.45; 95% CI, 1.62-3.69 for abnormal responses (P(trend).001). A positive gradient for CHD, CVD, and all-cause mortality rates across E-ECG categories within 3, 4, or 5 MetS components was observed (P.001 for all).Among men with MetS, an abnormal E-ECG response was associated with higher risk of all-cause, CVD, and CHD mortality. These findings underscore the importance of E-ECG tests to identify men with MetS who are at risk of dying. |
Databáze: | OpenAIRE |
Externí odkaz: |